Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.02
-0.44 (-2.67%)
At close: Feb 27, 2026, 4:00 PM EST
16.03
+0.01 (0.06%)
After-hours: Feb 27, 2026, 7:42 PM EST

Adaptive Biotechnologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
70.547.9265.0690.03139.07
Upgrade
Short-Term Investments
156.49174.37281.34408.17214
Upgrade
Cash & Short-Term Investments
226.98222.29346.4498.2353.06
Upgrade
Cash Growth
2.11%-35.83%-30.47%41.11%-48.70%
Upgrade
Accounts Receivable
50.3741.7337.9740.0617.41
Upgrade
Other Receivables
-1.310.81.4
Upgrade
Receivables
50.3743.0338.9740.8618.81
Upgrade
Inventory
9.828.4414.4514.4519.26
Upgrade
Prepaid Expenses
13.029.9910.378.6411.62
Upgrade
Total Current Assets
300.19283.75410.19562.15402.75
Upgrade
Property, Plant & Equipment
74.7294.38120.32164.21172.94
Upgrade
Long-Term Investments
13.2333.66--217.15
Upgrade
Goodwill
118.97118.97118.97118.97118.97
Upgrade
Other Intangible Assets
1.733.435.136.838.53
Upgrade
Other Long-Term Assets
3.95.186.524.463.01
Upgrade
Total Assets
512.74539.38661.13856.62923.34
Upgrade
Accounts Payable
6.477.277.728.083.31
Upgrade
Accrued Expenses
24.6920.6720.3924.122.2
Upgrade
Current Portion of Long-Term Debt
4.640.87---
Upgrade
Current Portion of Leases
8.9210.249.389.235.06
Upgrade
Current Income Taxes Payable
-0.180.060.190.39
Upgrade
Current Unearned Revenue
45.1955.6948.6364.1280.46
Upgrade
Other Current Liabilities
-3.151.844.072.39
Upgrade
Total Current Liabilities
89.9298.0588.02109.79113.81
Upgrade
Long-Term Debt
126.57132.41130.66125.36-
Upgrade
Long-Term Leases
70.2379.1589.3998.77106.69
Upgrade
Long-Term Unearned Revenue
1.0127.2644.7958.698.75
Upgrade
Other Long-Term Liabilities
0.020.02---
Upgrade
Total Liabilities
287.74336.89352.86392.52319.24
Upgrade
Common Stock
0.020.010.010.010.01
Upgrade
Additional Paid-In Capital
1,5821,5061,4531,3871,324
Upgrade
Retained Earnings
-1,363-1,304-1,144-919.08-718.89
Upgrade
Comprehensive Income & Other
0.250.170.22-4.12-1.14
Upgrade
Total Common Equity
218.79202.71308.4464.17603.99
Upgrade
Minority Interest
6.21-0.22-0.12-0.070.11
Upgrade
Shareholders' Equity
225202.49308.28464.1604.1
Upgrade
Total Liabilities & Equity
512.74539.38661.13856.62923.34
Upgrade
Total Debt
210.36222.67229.43233.36111.74
Upgrade
Net Cash (Debt)
29.8633.29116.97264.83458.47
Upgrade
Net Cash Growth
-10.30%-71.54%-55.83%-42.23%-34.41%
Upgrade
Net Cash Per Share
0.200.230.811.863.27
Upgrade
Filing Date Shares Outstanding
153.78148.58145.09143.23141.58
Upgrade
Total Common Shares Outstanding
153.78147.77145.08143.11141.39
Upgrade
Working Capital
210.27185.7322.17452.36288.94
Upgrade
Book Value Per Share
1.421.372.133.244.27
Upgrade
Tangible Book Value
98.180.31184.3338.37476.49
Upgrade
Tangible Book Value Per Share
0.640.541.272.363.37
Upgrade
Machinery
-59.3361.3656.748.88
Upgrade
Construction In Progress
-2.573.417.635.66
Upgrade
Leasehold Improvements
-73.2874.7372.465.96
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.